A nonrandomized, phase IV trial of FOLFIRI and cetuximab in first-line treatment of metastatic colorectal cancer receiving a predefined skin care and skin prophylaxis aiming to prevent a skin rash.

Goehler, T., Woerns, M.A., Hebart, H.F., Heike, M., Neise, M., Rudi, J., Geer, T., Dingeldein, G., Lang, C., Ehscheidt, P., Flohr, T., Josten, K.M., Karthaus, M., Schmittel, A.H., Wierecky, J., Galle, P.R., Dhensaw, C., Moehler, M.H., Schimanski, C.C., 2014.

J Clin Oncol 32 (suppl; abstr e20724). doi: 10.1200/jco.2014.32.15_suppl.e20724